Lars Henrik Høie

67 year

Commercial Services

Consumer Services

Health Technology

Profile

Lars Henrik Høie was the founder of Nutri Pharma ASA, which was founded in 1993, where he held the title of Research Director.
He was also the Chairman of Bionor Pharma ASA from 2011 to 2016.
Dr. Høie received a doctorate degree from the University of Oslo in 2011.

Former positions of Lars Henrik Høie

Companies	Position	End
Nutri Pharma ASA Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway	Founder	-
Bionor Pharma ASA Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.	Chairman	-

See the detail of Lars Henrik Høie's experience

Training of Lars Henrik Høie

University of Oslo

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lars Henrik Høie's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Nutri Pharma ASA Nutri Pharma ASA Miscellaneous Commercial ServicesCommercial Services Nutri Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases such as obesity, elevated cholesterol levels and diabetes. The firm's products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment). It develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The company was founded in 1993 and is headquartered in Oslo, Norway	Commercial Services
Bionor Pharma ASA Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.	Health Technology